EAM Investors, LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 176 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$796,000
-74.9%
221,011
-14.6%
0.21%
-52.3%
Q4 2014$3,169,000
+42.5%
258,703
+16.1%
0.44%
-2.2%
Q3 2014$2,224,000222,8420.45%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2015
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders